Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: A real-life study and cost-effectiveness analysis

Primary Care Respiratory Journal

Volumn 21, Issue 2, 2012, Pages 159-166

  Thorn, Jörgen ^a   Tilling, Björn ^b   Lisspers, Karin ^c   Jörgensen, Leif ^d   Stenling, Anna ^d   Stratelis, Georgios ^d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Primary Care ^*  (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

COPD; Copd 6; Cost effectiveness; Early diagnosis; Mini spirometer; Spirometry

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIMARY MEDICAL CARE; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY AIRFLOW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SMOKING; SPIROMETER; SPIROMETRY; SWEDEN;

AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; FORCED EXPIRATORY VOLUME; HEALTH CARE COSTS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; ROC CURVE; SMOKING; SPIROMETRY; VITAL CAPACITY;

EID: 84862651743     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2011.00104     Document Type: Article

References (36)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2009.
2. van Schayck CP, Levy ML, Stephenson P, Sheikh A. The IPCRG guidelines: developing guidelines for managing chronic respiratory diseases in primary care. Prim Care Respir J 2006;15(1):1-4. http://dx.doi.org/ 10.1016/j.pcrj.2005.12.003
3. Calverley PM. COPD: early detection and intervention. Chest 2000;117(5 Suppl 2):365-71S. http://dx.doi.org/10.1378/chest.117.5_suppl_2.365S
4. Lisspers K, Ställberg B, Hasselgren M, Johansson G, Svärdsudd K. Organisation of asthma care in primary health care in Mid-Sweden. Prim Care Respir J 2005;14(3):147-53. http://dx.doi.org/10.1016/j.pcrj.2005.03.003
5. Thorn J, Norrhall M, Larsson R, et al. Management of chronic obstructive pulmonary disease (COPD) in primary care: a questionnaire survey in western Sweden. Prim Care Respir J 2008;17(1):26-31. http://dx.doi.org/ 10.3132/pcrj.2008.00008
6. den Otter JJ, van Dijk B, van Schayck CP, Molema J, van Weel C. How to avoid underdiagnosed asthma/chronic obstructive pulmonary disease? J Asthma 1998;35(4):381-7. http://dx.doi.org/10.3109/02770909809075672
7. Nihlen U, Montnemery P, Lindholm LH, Lofdahl CG. Detection of chronic obstructive pulmonary disease (COPD) in primary health care: role of spirometry and respiratory symptoms. Scand J Prim Health Care 1999;17(4):232-7. http://dx.doi.org/ 10.1080/028134399750002467
8. Lindberg A, Bjerg A, Ronmark E, Larsson LG, Lundback B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006;100(2):264-72. http://dx.doi.org/10.1016/ j.rmed.2005.04.029
9. Tinkelman DG, Price D, Nordyke RJ, Halbert RJ. COPD screening efforts in primary care: what is the yield? Prim Care Respir J 2007;16(1):41-8. http://dx.doi.org/10.3132/pcrj.2007.00009
10. Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64(10):863-8. http://dx.doi.org/10.1136/thx.2009.115725
11. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006;61(12):1043-7. http://dx.doi.org/10.1136/ thx.2006.064410
12. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002;166(5):675-9. http://dx.doi.org/10.1164/rccm.2112096
13. Sauro A, Scalzitti F, Buono N, et al. Spirometry is really useful and feasible in the GP's daily practice but guidelines alone are not. Eur J Gen Pract 2005;11(1):29-31. http://dx.doi.org/10.3109/13814780509178015
14. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152(3):1107-36.
15. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13. http://dx.doi.org/ 10.1186/1477-7525-1-13
16. Statistics Sweden. May 2010. Available at: www.scb.se (accessed 9 June 2010).
17. Swedish Association of Local Authorities and Regions. December 2009. Available at: www.skl.se (accessed 9 June 2010).
18. XE. Available at: www.xe.com (accessed 26 September 2010).
19. Stratelis G, Jakobsson P, Molstad S, Zetterstrom O. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004;54(500):201-06.
20. Stratelis G, Molstad S, Jakobsson P, Zetterstrom O. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care 2006;24(3):133-9. http://dx.doi.org/10.1080/02813430600819751
21. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000;161(2 Pt 1):381-90.
22. Anthonisen N. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497-505. http://dx.doi.org/10.1001/jama.272.19.1497
23. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of overdiagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20(5):1117-22. http://dx.doi.org/10.1183/09031936.02.00023202
24. Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Postbronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006;173(12):1316-25. http://dx.doi.org/10.1164/rccm.200601-023OC
25. Price D, Crockett A, Arne M, et al. Spirometry in primary care case-identification, diagnosis and management of COPD. Prim Care Respir J 2009;18(3):216-23. http://dx.doi.org/10.4104/pcrj.2009.00055
26. Price D. Earlier diagnosis and earlier treatment of COPD in primary care. Prim Care Respir J 2010;20(1):15-22. http://dx.doi.org/10.4104/pcrj.2010.00060
27. National Institute for Health and Clinical Excellence (NICE). Available at: http://www.nice.org.uk.
28. Levy ML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn BP. International Primary Care Respiratory Group (IPCRG) guidelines: diagnosis of respiratory diseases in primary care. Prim Care Respir J 2006;15(1):20-34. http://dx.doi.org/ 10.1016/j.pcrj.2005.10.004
29. Derom E, van Weel C, Liistro G, et al. Primary care spirometry. Eur Respir J 2008;31(1):197-203. http://dx.doi.org/10.1183/09031936.00066607
30. Lusuardi M, De Benedetto F, Paggiaro P, et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in asthma and COPD: a comparative evaluation Italian study. Chest 2006;129(4):844-52. http://dx.doi.org/10.1378/chest.129.4.844
31. Yawn BP, Wollan PC. Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J COPD 2008;3(2):311-17.
32. US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148:529-34.
33. Jansson SA, Andersson F, Borg S, Ericsson A, Jonsson E, Lundback B. Costs of COPD in Sweden according to disease severity. Chest 2002;122(6):1994-2002. http://dx.doi.org/10.1378/chest.122.6.1994
34. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370(9589):765-73. http://dx.doi.org/10.1016/S0140-6736(07)61380-4
35. Sichletidis L, Spyratos D, Papaioannou M, et al. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J 2011;20:184-9. http://dx.doi.org/ 10.4104/pcrj.2011.00038
36. Frith P, Crockett A, Beilby J, et al. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim Care Respir J 2011;20:190-8. http://dx.doi.org/10.4104/pcrj.2011.00040